Lupus Clinical Trials in Wuhan, Hubei
21 recruitingWuhan, Hubei, China
Showing 1–20 of 21 trials
Recruiting
Phase 2
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Lupus Nephritis
Novartis Pharmaceuticals240 enrolled103 locationsNCT05268289
Recruiting
Phase 3
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
Lupus Nephritis
Novartis Pharmaceuticals462 enrolled188 locationsNCT05126277
Recruiting
Phase 3
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
AbbVie1,000 enrolled369 locationsNCT05843643
Recruiting
Not Applicable
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
SclerodermaMyasthenia Gravis (MG)System Lupus Erythematosus(SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology12 enrolled1 locationNCT07470151
Recruiting
Phase 3
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
Lupus Nephritis
Novartis Pharmaceuticals315 enrolled25 locationsNCT06711887
Recruiting
Phase 1Phase 2
A Study of GR1803 in Systemic Lupus Erythematosus
Systemic Lupus ErthematosusAuto Immune Disease
Genrix (Shanghai) Biopharmaceutical Co., Ltd.44 enrolled1 locationNCT07348055
Recruiting
Phase 4
Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease
Interstitial Lung DiseaseLupus or SLESystemic Lupus Erythematosus
Tongji Hospital100 enrolled1 locationNCT07077486
Recruiting
Phase 1Phase 2
Phase IIa Study for IPG11406 in Patients With Lupus Nephritis
Lupus Nephritis
Nanjing Immunophage Biotech Co., Ltd36 enrolled17 locationsNCT06717815
Recruiting
Early Phase 1
A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology12 enrolled1 locationNCT07339332
Recruiting
Early Phase 1
the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases
Recurrent or Refractory Systemic Lupus ErythematosusRecurrent or Refractory IgG4 Related DiseasesRecurrent or Refractory Systemic Sclerosis+2 more
Tongji Hospital45 enrolled1 locationNCT07339540
Recruiting
Phase 1
Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology12 enrolled1 locationNCT07031713
Recruiting
Phase 1
Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology25 enrolled2 locationsNCT06400537
Recruiting
Not Applicable
Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Tongji Hospital6 enrolled1 locationNCT06902844
Recruiting
Early Phase 1
A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology34 enrolled1 locationNCT06653556
Recruiting
Phase 1Phase 2
A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology15 enrolled1 locationNCT06106893
Recruiting
Phase 1Phase 2
A Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology15 enrolled1 locationNCT06106906
Recruiting
Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Tongji Hospital139 enrolled1 locationNCT06458972
Recruiting
Early Phase 1
Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease
IgG4-related DiseaseLupus Nephritis
Tongji Hospital30 enrolled1 locationNCT06497361
Recruiting
Early Phase 1
Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease
IgG4-related DiseaseLupus Nephritis
Tongji Hospital30 enrolled1 locationNCT06497387
Recruiting
Not Applicable
Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells
Lupus Nephritis
Lingli Dong24 enrolled1 locationNCT06277427